Psomagen, Inc. (KOSDAQ: 950200)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,150.00
-130.00 (-3.04%)
Dec 20, 2024, 9:00 AM KST
-19.42%
Market Cap 79.83B
Revenue (ttm) 38.14B
Net Income (ttm) -6.04B
Shares Out 19.24M
EPS (ttm) -345.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,616
Open 4,280.00
Previous Close 4,280.00
Day's Range 4,130.00 - 4,340.00
52-Week Range 3,765.00 - 6,700.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About Psomagen

Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes. The company provides genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, offered to analyze the impact of gene expression on the biology of an organism; and p... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Employees 89
Stock Exchange KOSDAQ
Ticker Symbol 950200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.